Glycine-extended gastrin promotes the invasiveness of human colon cancer cells

被引:64
作者
Kermorgant, S [1 ]
Lehy, T [1 ]
机构
[1] Fac Med Xavier Bichat, INSERM, Unite U 410, IFR2 Physiol & Pathol, F-75870 Paris 18, France
关键词
glycine-extended gastrin; matrix metalloproteinase; colon cancer cell; CCK-B receptor antagonist; zymography; cell invasion;
D O I
10.1006/bbrc.2001.5132
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Colorectal cancers express significant amounts of immature glycine-extended gastrin (G-Cly) and G-GIST is able to stimulate cell proliferation in colonic cell lines and mucose. Here we wished to investigate whether G17-Gly promote the invasiveness of LoVo human colonic cancer cells, a process which requires degradation of extracellular matrix by proteases and concomitant induction of cell migration. We confirmed that LoVo cells express gastrin and gastrin/CCK-B receptor mRNAs, We showed that these cells secrete matrix metalloproteinase (MMP)-1, -2, and -9. The function of MMP being to degrade components of extracellular matrix, they may thus favor cell migration. As compared to controls, G17-Gly (10(-7) to 10(-12) M) significantly enhanced about two to three times the LoVo cell migration through Matrigel, an artificial basement matrix barrier. Moreover, G17-Gly increased and gastrin/CCK-B receptor antagonists decreased MMP secretion in conditioned culture media of LoVo cells. Our findings show that physiological doses of incompletely processed form of gastrin induce the invasiveness of tumor cells in vitro and suggest a novel potential role for this peptide in the metastatic process of colonic cancers in vivo. (C) 2001 Academic Press.
引用
收藏
页码:136 / 141
页数:6
相关论文
共 30 条
  • [11] LEHY T, 1973, GASTROENTEROLOGY, V64, P421
  • [12] CANCER INVASION AND METASTASES
    LIOTTA, LA
    KOHN, E
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1990, 263 (08): : 1123 - 1126
  • [13] Litvak DA, 1999, ANTICANCER RES, V19, P45
  • [14] Coexpression of gastrin and gastrin receptors (CCK-B and ΔCCK-B) in gastrointestinal tumour cell lines
    McWilliams, DF
    Watson, SA
    Crosbee, DM
    Michaeli, D
    Seth, R
    [J]. GUT, 1998, 42 (06) : 795 - 798
  • [15] Antiproliferative effect of a novel cholecystokinin-B/gastrin receptor antagonist, YM022
    Murayama, T
    Matsumori, Y
    Iwata, N
    Ito, M
    Taniguchi, T
    Chihara, K
    Matsui, T
    [J]. JAPANESE JOURNAL OF CANCER RESEARCH, 1996, 87 (07): : 743 - 750
  • [16] IDENTIFICATION OF PROGASTRIN DERIVED PEPTIDES IN COLORECTAL-CARCINOMA EXTRACTS
    NEMETH, J
    TAYLOR, B
    PAUWELS, S
    VARRO, A
    DOCKRAY, GJ
    [J]. GUT, 1993, 34 (01) : 90 - 95
  • [17] NISHIDA A, 1994, J PHARMACOL EXP THER, V269, P725
  • [18] Prolonged hypergastrinemia does not increase the frequency of colonic neoplasia in patients with Zollinger-Ellison syndrome
    Orbuch, M
    Venzon, DJ
    Lubensky, IA
    Weber, HC
    Gibril, F
    Jensen, RT
    [J]. DIGESTIVE DISEASES AND SCIENCES, 1996, 41 (03) : 604 - 613
  • [19] GASTRIN AND COLORECTAL-CANCER - A NEVER-ENDING DISPUTE
    REHFELD, JF
    [J]. GASTROENTEROLOGY, 1995, 108 (04) : 1307 - 1310
  • [20] GROWTH-PROMOTING EFFECTS OF GLYCINE-EXTENDED PROGASTRIN
    SEVA, C
    DICKINSON, CJ
    YAMADA, T
    [J]. SCIENCE, 1994, 265 (5170) : 410 - 412